Biotech Values

[iwfal]

Today’s NYT article on Pradaxa is a textbook case of bias stemming from asymmetric information:

Given that there is indisputably one real meaningful problem and a second highly probable problem I would suggest it isn't very textbook. This is not to say that the problem you mention isn't real in the sense that it will exaggerate the SAE.